SHANGHAI PHARMACEUTICALS HOLDINGS CO., LTD. (SHPMY)
Clinical trial NCT06535412 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. completion date: 2026-06-10 → 2028-12-17 3. primary completion date: 2025-12-10 → 2028-12-17
Clinical trial NCT06535412 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. completion date: 2026-06-10 → 2028-12-17 3. primary completion date: 2025-12-10 → 2028-12-17
Clinical trial NCT07335510 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-01-01 → 2026-03-30
Clinical trial NCT07538843: start date: 2026-06-01 → 2026-07-30.
Clinical trial NCT02724163: status: RECRUITING → ACTIVE_NOT_RECRUITING.
Clinical trial NCT07600749 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-06-15 → 2026-06-18
Clinical trial NCT06666504 updates: 1. status: NOT_YET_RECRUITING → COMPLETED 2. start date: 2024-12-01 → 2024-12-11 3. completion date: 2026-06-30 → 2026-06-20 4. primary completion date: 2025-12-30 → 2026-06-20 5. enrollment type: ESTIMATED → ACTUAL 6. collaborators added: AstraZeneca
Clinical trial NCT07467707 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-05-01 → 2026-05-26
Clinical trial NCT07549490: start date: 2026-07-01 → 2026-07-02.
Clinical trial NCT06052631: start date: 2026-07-01 → 2026-07-02.
Clinical trial NCT05820841 updates: 1. completion date: 2028-12-01 → 2029-02-01 2. primary completion date: 2028-04-01 → 2029-02-01